DPP4 and dementia: The relative risk estimates for all-cause dementia with GLP1 receptor agonists versus DPP4 inhibitors did not significantly differ (p = 0.708) between those aged 60–70 (HR [95% CI]: 0.91 [0.81–1.03]) and > 70 years (HR [95% CI]: 0.95 [0.83–1.08]).